Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Detection and Purification

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic nine-residue tag derived from the human influenza virus hemagglutinin protein. It is widely used as a molecular tag for protein detection, purification, and elution in immunoprecipitation and protein interaction assays (APExBIO A6004). The peptide displays high solubility (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water) and >98% purity by HPLC/mass spectrometry, ensuring reproducibility across workflows (Wei et al., 2021). It functions by competitively binding to anti-HA antibodies, facilitating the elution of HA-tagged proteins in immunoprecipitation. The HA tag is extensively validated for exosome pathway research and protein-protein interaction studies (EpitopePeptide.com).

Biological Rationale

The HA tag peptide is derived from the influenza virus hemagglutinin protein's epitope region, a site recognized by monoclonal anti-HA antibodies (Wei et al., 2021). This nine-amino-acid sequence (YPYDVPDYA) is not commonly found in eukaryotic proteomes, reducing off-target interactions and enabling specific detection of tagged recombinant proteins. The use of the HA tag facilitates the isolation, quantification, and visualization of fusion proteins in diverse mammalian and non-mammalian systems. Its application is fundamental to studies on vesicular transport, exosome biogenesis, and the evaluation of protein-protein interactions, as highlighted in advanced exosome pathway research (EpitopePeptide.com), which this article extends by detailing solubility, validated purity, and workflow integration.

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA tag peptide serves as a competitive ligand for anti-HA antibodies. When HA-tagged fusion proteins are bound to antibody-coated beads (e.g., anti-HA magnetic beads), the addition of excess free HA peptide displaces the fusion protein via competitive binding, enabling its gentle elution without denaturation (APExBIO product page). The process exploits the high affinity and specificity of the anti-HA antibody for the conserved YPYDVPDYA epitope. The peptide’s high solubility in water, ethanol, and DMSO allows for flexible buffer selection and compatibility with a wide range of protein samples. Structural studies confirm that the epitope-antibody interaction is robust under physiological conditions, and the peptide’s sequence remains stable under storage at -20°C, preserving its functional integrity for repeated experimental use (FDX1-mRNA.com).

Evidence & Benchmarks

• HA peptide (YPYDVPDYA) shows high-affinity, sequence-specific binding to monoclonal anti-HA antibodies, as validated by ELISA and immunoprecipitation assays (Wei et al., 2021).
• The peptide achieves ≥98% purity, confirmed by high-performance liquid chromatography and mass spectrometry, under standard QC conditions (APExBIO).
• Solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water at ambient temperature (RT, ~22°C) (APExBIO).
• HA peptide enables competitive elution of HA-tagged proteins from anti-HA antibody beads in immunoprecipitation workflows, preserving native protein conformation (Angiotensin-1-2-1-9.com).
• Use of the HA tag peptide in exosome research has facilitated the elucidation of ESCRT-independent pathways by enabling selective detection of tagged proteins within multivesicular endosomes (Wei et al., 2021).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is extensively used in:

• Protein purification workflows employing HA-tagged constructs.
• Immunoprecipitation and co-immunoprecipitation assays for protein-protein interaction studies.
• Detection and quantification of HA-tagged proteins by western blot, ELISA, or immunofluorescence.
• Advanced exosome pathway and vesicular trafficking research, as described in related analyses.

Recent studies, such as those by Wei et al. (2021), leverage the HA tag to dissect mechanisms of exosome biogenesis and membrane protein sorting (DOI). This article clarifies the peptide's validated solubility and purity, extending the focus of FDX1-mRNA.com by providing explicit workflow compatibility data.

Common Pitfalls or Misconceptions

• The HA tag peptide does not confer biological activity to the fusion protein; it serves solely as an epitope tag for detection and purification.
• Excessive or prolonged storage of peptide solutions (even at -20°C) can reduce activity due to hydrolysis; always store lyophilized and desiccated.
• The HA peptide sequence may not be suitable for all antibody clones; always verify antibody compatibility before use.
• Not all fusion proteins retain full function after tagging; empirical validation is required for each construct.
• HA peptide is not a substitute for structural or functional protein analysis; it is a tool for detection and purification only.

Workflow Integration & Parameters

The HA peptide (A6004) from APExBIO integrates seamlessly into standard immunoprecipitation, protein purification, and protein interaction protocols. For elution, typical concentrations range from 0.5–2 mg/mL in phosphate-buffered saline (PBS, pH 7.4), with incubation at 4°C for 30–60 minutes to ensure efficient displacement of HA-tagged proteins. The peptide's high solubility in multiple solvents supports adaptation to diverse buffer systems, minimizing precipitation or aggregation and supporting sensitive downstream analyses. Benchmarked protocols demonstrate that the peptide’s purity and competitive binding efficiency are key to reproducible results in both routine and advanced laboratory settings (Angiotensin-1-2-1-9.com). This article provides detailed solubility and performance data, updating the best-practice recommendations from GTP-Binding-Protein-Fragment-G-Alpha.com by quantifying solubility and storage benchmarks.

Ensure all reagents (antibodies, beads, buffers) are compatible and free from interfering substances (e.g., proteases or detergents that may degrade the peptide or disrupt antibody binding). The use of freshly prepared peptide solutions is recommended for maximal efficiency.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide (SKU A6004) from APExBIO is a validated, high-purity epitope tag supporting reliable protein detection, purification, and elution in molecular biology. Its proven solubility, sequence specificity, and compatibility with immunoprecipitation workflows underlie its widespread adoption in protein-protein interaction and exosome research. Ongoing innovations in exosome pathway studies and translational protein science will continue to leverage the HA tag, while rigorous application protocols and awareness of limitations ensure reproducibility and data integrity (Perylene-Azide.com).